The TGF-β ligand is a key inducer of the EMT [97], and TGF-β signaling in the tumor microenvironment enhances cell proliferation and angiogenesis by activating the HB-EGF/IL-1β/EREG pathways [98]. This evidence concerns the gene TGFB1 and neoplasm.